Source - GNW

BLOCK LISTING SIX MONTHLY RETURN

 (Note: Italicised terms have the same meaning as given in the Listing Rules.)

Date: 6 April 2018

Name of applicant: Summit Therapeutics plc
Name of scheme: 2005 EMI Scheme
Period of return: From: 23 Oct 2017 To: 05 Apr 2018
Balance of unallotted securities under scheme(s) from previous return: 4,454,158
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): Zero
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 2,884
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: 4,451,274

Name of applicant: Summit Therapeutics plc
Name of scheme: 2016 Long term Incentive Plan
Period of return: From: 23 Oct 2017 To: 05 Apr 2018
Balance of unallotted securities under scheme(s) from previous return: 3,535,549
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 701,496
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 1,332
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: 4,235,713

Name of contact: Richard Pye
Telephone number of contact: +44 (0)1235 443951



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Summit Therapeutics plc via Globenewswire

Related Charts

Summit Therapeutics (SUMM)

+5.00p (+2.56%)
delayed 07:31AM